the addition of venetoclax to hmas for the treatment of cmml: a retrospective psm analysis
Published 7 months ago • 121 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
2:19
the addition of venetoclax to hyper-cvad-nelarabine and pegylated asparagine in t-all
-
4:26
retrospective analysis of venetoclax-based therapy in cmml
-
1:09
dec-c plus venetoclax in hr-mds and cmml: an analysis using different response criteria
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
0:51
phase i study of copanlisib plus venetoclax in r/r dlbcl
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
4:48
the evolution of allosct in richter's transformation and its combination with biological agents
-
7:52
whole exome sequencing
-
3:09
bleximenib combined with venetoclax and azacitidine in r/r aml with kmt2a or npm1 alterations
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
2:38
the boven trial: mrd-guided obinutuzumab, zanubrutinib and venetoclax regimen in tp53-mutated mcl
-
3:52
venetoclax & aml
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
3:19
an update on two trials evaluating venetoclax in subsets of cll
-
2:20
pevonedistat, azacitidine and venetoclax triplet therapy for aml, mds and cmml
-
1:22
responses to olutasidenib in patients with aml who have failed treatment with venetoclax
-
2:24
judging the value of a clinical trial in hem-onc
-
2:19
cladribine ldac venetoclax alternated with azacitidine venetoclax in older patients with aml
-
1:22
promising outlooks for venetoclax combinations for mm
-
1:33
understanding the mechanisms of venetoclax and ibrutinib resistance